X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (822) 822
Publication (82) 82
Newspaper Article (34) 34
Web Resource (16) 16
Book / eBook (8) 8
Book Chapter (4) 4
Book Review (3) 3
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (245) 245
index medicus (232) 232
hematology (178) 178
oncology (146) 146
female (144) 144
male (142) 142
middle aged (137) 137
aged (136) 136
myelodysplastic syndromes (95) 95
adult (92) 92
leukemia (88) 88
cancer (80) 80
aged, 80 and over (76) 76
treatment outcome (75) 75
prognosis (72) 72
myelodysplastic syndromes - drug therapy (62) 62
acute myeloid-leukemia (61) 61
risk factors (55) 55
myelodysplastic syndromes - genetics (53) 53
abridged index medicus (51) 51
mutation (48) 48
mds (44) 44
scoring system (44) 44
survival (44) 44
chemotherapy (39) 39
hematology, oncology and palliative medicine (39) 39
azacitidine (36) 36
care and treatment (35) 35
myelodysplastic syndrome (35) 35
mutations (34) 34
myelodysplastic syndromes - diagnosis (34) 34
patients (34) 34
article (33) 33
myelodysplastic syndromes - pathology (33) 33
adolescent (31) 31
bone marrow (31) 31
myelodysplastic syndromes - mortality (31) 31
research (31) 31
young adult (31) 31
leukemia, myeloid, acute - drug therapy (30) 30
myelodysplastic syndromes - therapy (30) 30
acute myeloid leukemia (29) 29
antineoplastic agents - therapeutic use (29) 29
classification (28) 28
lenalidomide (27) 27
leukemia, myeloid, acute - genetics (26) 26
remission induction (26) 26
survival analysis (26) 26
survival rate (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
decitabine (25) 25
hemic and lymphatic diseases (25) 25
retrospective studies (25) 25
therapy (25) 25
leukemia, myeloid, acute - mortality (24) 24
transplantation (24) 24
risk (23) 23
azacitidine - analogs & derivatives (21) 21
phase-iii (21) 21
diagnosis (20) 20
thalidomide - analogs & derivatives (20) 20
antimetabolites, antineoplastic - therapeutic use (19) 19
azacitidine - therapeutic use (19) 19
colony-stimulating factor (19) 19
cytarabine - administration & dosage (19) 19
disease progression (19) 19
disease-free survival (19) 19
efficacy (19) 19
international working group (19) 19
response criteria (19) 19
acute myelogenous leukemia (18) 18
aml (18) 18
myeloid neoplasia (18) 18
analysis (17) 17
cytogenetics (17) 17
hematopoietic stem cell transplantation (17) 17
medical research (17) 17
thalidomide - therapeutic use (17) 17
chromosome aberrations (16) 16
genetic aspects (16) 16
leukemia, myeloid, acute - pathology (16) 16
older patients (16) 16
patient outcomes (16) 16
chromosome deletion (15) 15
cohort studies (15) 15
impact (15) 15
prognostic scoring system (15) 15
world-health-organization (15) 15
age factors (14) 14
azacitidine - administration & dosage (14) 14
clinical trials (14) 14
follow-up studies (14) 14
karyotyping (14) 14
polymorphism, single nucleotide (14) 14
recurrence (14) 14
animals (13) 13
chronic myelomonocytic leukemia (13) 13
drug administration schedule (13) 13
leukemia, myeloid, acute - diagnosis (13) 13
myelodysplastic syndromes - classification (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2017, Fifth edition., ISBN 9781119196204, 1299
The fifth edition of the only comprehensive text dealing exclusively with rare or infrequently encountered malignancies in adults and children is an essential... 
Rare Diseases | Neoplasms | Tumors
Book
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 13, pp. 1374 - 1375
Journal Article
Leukemia, ISSN 0887-6924, 03/2019, Volume 33, Issue 3, pp. 570 - 575
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2016, Volume 34, Issue 25, pp. 2956 - 2957
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2499 - 2499
Myeloid malignancies can evolve from prior hematologic disorders, most commonly AML evolving from MDS. AA and PNH are not malignant conditions but they can... 
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 13, pp. 1374 - 1374
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5043 - 5043
Systematic application of NGS has led to the discovery of a myriad of somatic mutations. One important class of genes affected by mutations in myeloid... 
Journal Article
Annual Review of Medicine, ISSN 0066-4219, 01/2017, Volume 68, pp. 127 - 127
Precision medicine can be simply defined as the identification of personalized treatment that matches patient-specific clinical and genomic characteristics.... 
Journal Article
Annual Review of Medicine, ISSN 0066-4219, 01/2017, Volume 68, p. 127
  Precision medicine can be simply defined as the identification of personalized treatment that matches patient-specific clinical and genomic characteristics.... 
Proteins | Genomics | Medical treatment | Leukemia | Mutation
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3836 - 3836
Background: Determining which AML patients (pts) are "fit" for intensive chemotherapy (IC), both in real-world scenarios and for clinical trial eligibility... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2590 - 2590
Abstract Based on clinical Camitta criteria, acquired aplastic anemia is categorized according to the degree of blood count depression as severe (sAA) or... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1824 - 1824
Abstract Morphology has dominated the diagnosis and classification of MDS for decades. With the advent of NGS, morphology is used as a gold standard to assess... 
Journal Article
Best Practice & Research Clinical Haematology, ISSN 1521-6926, 12/2018, Volume 31, Issue 4, pp. 346 - 350
Therapies for myelodysplastic syndromes (MDS) are chosen depending on whether a patient has lower- or higher-risk disease. Hypomethylating agents are... 
MDS | Hypomethylating agents | Myelodysplastic syndromes | Transplant | LOW-DOSE DECITABINE | ACUTE MYELOID-LEUKEMIA | AZACITIDINE | CHEMOTHERAPY | CARE | LOW-RISK | SCORING SYSTEM | INTERGROUP | HEMATOLOGY | Chemotherapy | Transplantation | Hematopoietic stem cells | Cancer
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2992 - 2992
Myelodysplastic syndromes (MDS) arise in older adults through the stepwise acquisition of multiple somatic mutations. The genetic heterogeneity that results... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.